Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis

Journal of General Virology

Volumn 78, Issue 6, 1997, Pages 1295-1302

  Fournier, Philippe ^a   Brons, Nicolas H C ^a   Berbers, Guy A M ^b   Wiesmüller, Karl Heinz ^c   Fleckenstein, Burkhard T ^c   Schneider, François ^a   Jung, Günther ^c   Muller, Claude P ^a,d  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ARTICLE; HEMAGGLUTINATION; HEMOLYSIS; HUMAN; HUMAN CELL; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS ENCEPHALITIS;

EID: 0030996747     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-6-1295     Document Type: Article

References (50)

1. Albrecht, P., Ennis, A., Soltzman, E. J. & Krugman, S. (1977). Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. Journal of Pediatrics 91, 715-718.
2. Alkhatib, G. & Briedis, D. J. (1986). The predicted primary structure of the measles virus hemagglutinin. Virology 150, 479-490.
3. Bartz, R., Brinckmann, U., Dunster, L. M., Rima, B., ter Meulen, V. & Schneider-Schaulies, J. (1996). Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology 224, 334-337.
4. Beauverger, P., Buckland, R. & Wild, F. (1993). Establishment and characterisation of murine cells constitutively expressing the fusion, nucleoprotein and matrix proteins of measles virus. Journal of Virological Methods 44, 199-210.
5. Beauverger, P., Buckland, R. & Wild, T. F. (1994). Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. Journal of General Virology 74, 2357-2363.
6. Carter, M. J., Willcocks, M. M., Löffler, S. & ter Meulen, V. (1982). Relationships between monoclonal antibody-binding sites on the measles virus haemagglutinin. Journal of General Virology 63, 113-120.
7. Diamond, B., Boccumini, L. & Birshtein, B. K. (1985). Site of binding of IgG2b and IgG2a by mouse macrophage Fc receptors by using cyanogen bromide fragments. Journal of Immunology 134, 1080-1083.
8. Dunster, L. M., Schneider-Schaulies, J., Löffler, S., Lankes, W., Schwartz-Albiez, R., Lottspeich, F. & ter Meulen, V. (1994). Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology 198, 265-274.
9. Fournier, P., Ammerlaan, W., Ziegler, D., Giminez, C., Rabourdin-Combe, C., Fleckenstein, B., Wiesmueller, K. H., Jung, G., Schneider, F. & Muller, C. P. (1996). Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides. International Immunology 8, 1441-1451.
10. Fulginiti, V. A., Eller, J. J., Downie, A. W. & Kempe, C. H. (1967). Altered reactivity to Measles virus. Journal of the American Medical Association 202, 1075-1080.
11. Gerlier, D., Varior-Krishnan, G. & Devaux, P. (1995). CD46-mediated measles entry: a first key to host-range specificity. Trends in Microbiology 3, 338-345.
12. Giraudon, P. & Wild, T. F. (1985). Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144, 46-58.
13. Hu, A., Sheshberadaran, H., Norrby, E. & Kovamees, J. (1993). Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology 192, 351-354.
14. Hu, A., Cattaneo, R., Schwartz, S. & Norrby, E. (1994). Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. Journal of General Virology 75, 1043-1052.
15. Hummel, K. B. & Bellini, W. J. (1995). Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. Journal of Virology 69, 1913-1916.
16. Ishizaka, S. T., Piacente, P., Silva, J. & Mishkin, E. M. (1995). IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes virus glycoprotein D monoclonal antibodies. Journal of Infectious Diseases 172, 1108-1111.
17. Lecouturier, V., Fayolle, J., Caballero, M., Carabara, J., Celma, M. L., Fernandez-Munoz, R., Wild, T. F. & Buckland, R. (1996). Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. Journal of Virology 70, 4200-4204.
18. Liebert, U. G. & ter Meulen, V. (1987). Virological aspects of measles virus-induced encephalomyelitis in Lewis and BN rats. Journal of General Virology 68, 1715-1722.
19. Liebert, U. G., Flanagan, S. G., Löffler, S., Baczko, K., ter Meulen, V. & Rima, B. K. (1994). Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. Journal of Virology 68, 1486-1493.
20. Mäkela, M. J., Norrby, E. & Salmi, A. (1987). Measurement of polypeptide-and antigenic site-specific antibodies to measles virus using a competitive enzyme immunoassay. Journal of Virological Methods 16, 65-74.
21. Mäkela, M. J., Salmi, A. A., Norrby, E. & Wild, T. F. (1989a). Monoclonal antibodies against measles virus haemagglutinin react with synthetic peptides [published erratum appears in Scand.]. Immunol. 1990 Apr; 31(4): 541]. Scandinavian Journal of Immunology 30, 225-231.
22. Mäkela, M. J., Lund, G. A. & Salmi, A. A. (1989b). Antigenicity of the measles virus haemagglutinin studied by using synthetic peptides. Journal of General of Virology 70, 603-614.
23. Malvoisin, E. & Wild, F. (1990). Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. Journal of Virology 64, 5160-5162.
24. Malvoisin, E. & Wild, F. (1994). The role of N-glycosylation in cell fusion induced by a vaccinia recombinant virus expressing both measles virus glycoproteins. Virology 200, 11-20.
25. Muller, C. P., Schroeder, T., Tu, R., Brons, N. H. C., Jung, G., Schneider, F. & Wiesmüller, K. H. (1993). Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein. Scandinavian Journal of Immunology 38, 463-471.
26. Muller, C. P., Beauverger, P., Schneider, F., Jung, G. & Brons, N. H. C. (1995). Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus. Journal of General Virology 76, 1371-1380.
27. Naniche, D., Varior Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin Combe, C. & Gerlier, D. (1993). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. Journal of Virology 67, 6025-6032.
28. Neuberger, M. S. & Rajewsky, K. (1981). Activation of mouse complement by mouse monoclonal antibodies. European Journal of Immunology 11, 1012-1016.
29. Nokes, D. J. & Cutts, F. T. (1993). Immunization in the developing world: strategic challenges. Transactions and Research Social Tropical Medical Hygiene 87, 353-354, 398.
30. Norrby, E. & Gollmar, Y. (1972). Appearance and persistence of antibodies against different virus components after regular measles infections. Infection and Immunity 6, 240-247.
31. Norrby, E. & Gollmar, Y. (1975). Identification of measles virus-specific hemolysis-inhibiting antibodies separate from hemagglutination-inhibiting antibodies. Infection and Immunity 11, 231-239.
32. Norrby, E., Enders-Ruckle, G. & ter Meulen, V. (1975). Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live viruses. Journal of Infectious Diseases 132, 262-269.
33. Obeid, O. E. & Steward, M. W. (1994). The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice. Immunology 82, 16-21.
34. Obeid, O. E., Partidos, C. D. & Steward, M. W. (1994). Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides. Virus Research 32, 69-84.
35. Obeid, O. E., Partidos, C. D., Howard, C. R. & Steward, M. W. (1995). Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B-and T-cell epitopes from the fusion protein of measles virus. Journal of Virology 69, 1420-1428.
36. Orvell, C. (1976). Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. Acta Pathologica et Microbiologica Scandinavica Section B 84, 441-450.
37. Parry, N., Fox, G., Rowlands, D., Brown, F., Fry, E., Acharya, R., Logan, D. & Stuart, D. (1990). Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347, 569-572.
38. Piga, N., Kessler, N., Layani, M. P. & Aymard, M. (1990). Correlation between the reactivity patterns of monoclonal antibodies to distinct antigenic sites on HN glycoprotein and their protective abilities in Sendai (6/94) virus infection. Archives of Virology 110, 179-193.
39. Ravetch, J. V. & Kinet, J. P. (1991). Fc receptors. Annual Review of Immunology 9, 457-492.
40. Rota, J. S., Hummel, K. B., Rota, P. A. & Bellini, W. J. (1992). Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188, 135-142.
41. Sheshberadaran, H. & Norrby, E. (1986). Characterization of epitopes on the measles virus hemagglutinin. Virology 152, 58-65.
42. Sheshberadaran, H. & Payne, L. G. (1988). Protein antigen-monoclonal antibody contact sites investigated by limited proteolysis of monoclonal antibody-bound antigen: protein "footprinting". Proceedings of the National Academy of Sciences, USA 85, 1-5.
43. Shibahara, K., Hotta, H., Katayama, Y. & Homma, M. (1994). Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. Journal of General Virology 75, 3511-3516.
44. Stern, L. B., Greenberg, M., Gershoni, J. M. & Rozenblatt, S. (1995). The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. Journal of Virology 69, 1661-1668.
45. Steward, M. W., Stanley, C. M. & Obeid, O. E. (1995). A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response. Journal of Virology 69, 7668-7673.
46. Tamin, A., Rota, P. A., Wang, Z. D., Heath, J. L., Anderson, L. J. & Bellini, W. J. (1994). Antigenic analysis of current wild type and vaccine strains of measles virus. Journal of Infectious Diseases 170, 795-801.
47. Tsurudome, M., Yamada, A., Hishiyama, M. & Ito, Y. (1986). Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody. Journal of General Virology 67, 2259-2265.
48. Wiesmuller, K. H., Spahn, G., Handtmann, D., Schneider, F., Jung, G. & Muller, C. P. (1992). Heterogeneity of linear B cell epitopes of the measles virus fusion protein reacting with late convalescent sera. Journal of General Virology 73, 2211-2216.
49. Wild, T. F., Malvoisin, E. & Buckland, R. (1991). Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. Journal of General Virology 72, 439-442.
50. Ziegler, D., Fournier, P., Berbers, G. A. M., Steuer, H., Wiesmüller, K. H., Fleckenstein, B., Schneider, F., Jung, G., King, C. C. & Muller, C. P. (1996). Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies. Journal of General Virology 77, 2479-2489.